Interplay Bio
MI - YpsilantiBiotechnology
Focus: Interplay Bio is a biotechnology company focused on the LigandPro Platform for targeted protein degradation, with a specialization in oncology therapeutics. The company is based in Ypsilanti, Michigan and operates in the pre-clinical to early-stage development space.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Open Jobs
10+10 this month
Growing — net +10 jobs in 30d
10 jobs added vs 0 removed. Steady team buildout.
Should You Work at Interplay Bio?
AI assessmentInterplay Bio represents a speculative early-stage opportunity suitable only for risk-tolerant scientists committed to platform technology development, not for career-builders seeking near-term clinical validation or financial security.
Why Work Here
- Opportunity to work on cutting-edge targeted protein degradation technology (LigandPro Platform) in a growing modality space
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Interplay Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.